Ironwood Pharmaceuticals (IRWD) Debt Ratio (2012 - 2026)

Ironwood Pharmaceuticals has disclosed Debt Ratio across 15 years of filings, most recently posting 1.35 for Q2 2026.

• In Q2 2026, Debt Ratio fell 20.75% year-over-year to 1.35; the TTM figure through Jun 2026 stood at 1.35 (down 20.75% YoY), while the FY2025 annual figure was 1.47, up 34.27% from the prior year.
• Debt Ratio came in at 1.35 for Q2 2026 at Ironwood Pharmaceuticals, roughly flat from 1.35 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 1.7 in Q2 2025 to a low of 0.0 in Q3 2022.
• Average Debt Ratio over 5 years is 0.94, with a median of 1.07 recorded in 2024.
• Year-over-year, Debt Ratio plunged 100.0% in 2022 and jumped 104085516.89% in 2023.
• Over 5 years, Debt Ratio stood at 0.0 in 2022, then jumped by 6142374.86% to 1.06 in 2023, then rose by 3.46% to 1.1 in 2024, then soared by 34.27% to 1.47 in 2025, then retreated by 8.34% to 1.35 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 1.35 in Q2 2026, 1.35 in Q1 2026, and 1.47 in Q4 2025.